Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today’s top gainers. The company’s shares are currently up 56.51% on the day to $9.86.
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 development for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the 3rd line treatment of renal cell carcinoma; and IXEMPRA, a microtubule inhibitor.
So far today, approximately 5.1M shares of Allarity Therapeutics Inc have been exchanged, as compared to an average 30-day volume of 2.22M shares.
Allarity Therapeutics Inc share prices have moved between a 52-week high of $3,276 and a 52-week low of $6. The stock has moved 3,610% over the past week.
To learn more about Allarity Therapeutics Inc, visit the company’s website at https://www.allarity.com.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com